Potentiation of sensory tachykininergic and parasympathetic cholinergic transmission by epidermal growth factor.
Muramatsu
I
I
Department of Pharmacology, Fukui Medical School, Japan.
Hollenberg
M D
MD
D000109:Acetylcholine / Q000494:pharmacology*; D000527:Alprostadil / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002211:Capsaicin / Q000494:pharmacology; D004815:Epidermal Growth Factor / Q000494:pharmacology*; D005260:Female; D019833:Genistein; D066298:In Vitro Techniques; D007213:Indomethacin / Q000494:pharmacology; D007498:Iris / Q000187:drug effects / Q000294:innervation / Q000502:physiology*; D007529:Isoflavones / Q000494:pharmacology; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects*; D009130:Muscle, Smooth / Q000187:drug effects / Q000294:innervation / Q000502:physiology*; D010276:Parasympatholytics / Q000494:pharmacology; D011817:Rabbits; D009435:Synaptic Transmission / Q000187:drug effects*; D015320:Tachykinins / Q000502:physiology
D007529:Isoflavones; D010276:Parasympatholytics; D015320:Tachykinins; D004815:Epidermal Growth Factor; D001285:Atropine; D019833:Genistein; D000527:Alprostadil; D000109:Acetylcholine; D002211:Capsaicin; D007213:Indomethacin